$92 million investment in adMare BioInnovations will help translate health research into innovative new therapies in Canada
March 30, 2022 – Vancouver, British Columbia
Protecting the health and safety of Canadians and ensuring we have the national capacity to respond to future health crises are top priorities for the Government of Canada. Guided by Canada’s Biomanufacturing and Life Sciences Strategy, the Government is actively supporting the growth of a strong and competitive national life sciences sector with leading biomanufacturing capabilities.
Today, the Honorable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a $92 million investment in adMare BioInnovations to drive innovation, scale and formation of companies in the life sciences sector in Canada. This investment will help transform commercially promising health research into innovative new therapies and enable Canadian anchor companies to provide the training needed and drive the growth of Canadian life sciences companies.
Through adMare’s Innovation Centers in Vancouver and Montreal, entrepreneurs, academic researchers, innovators and emerging Canadian small and medium-sized enterprises (SMEs) can access a full range of services, including scientific expertise , research infrastructure and business development support, as well as funding for new research and development projects with high commercial potential.
Canada is developing its diverse talent pool and research systems while attracting industry leaders to transform innovative ideas into the scientific discoveries of tomorrow. The government will continue to focus on improving the health of Canadians, restarting the economy and creating well-paying jobs for Canadians.